erythromycin has been researched along with cefditoren in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O | 1 |
| Hijioka, S; Inoue, S; Kugo, Y; Nishimura, T; Oguni, T; Sugiki, M; Sugita, K; Uemura, T; Wakamiya, E; Yoshikawa, K | 1 |
| Coronel, P; Del Río, I; Domenech, M; Gimeno, M; González-Camacho, F; Lago, D; Llamosí, M; López Ruiz, B; Pérez-García, C; Sempere, J; Yuste, J | 1 |
1 review(s) available for erythromycin and cefditoren
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for erythromycin and cefditoren
| Article | Year |
|---|---|
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinolones; Fusidic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillins; Skin Diseases, Bacterial; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin | 1999 |
[Antimicrobial susceptibility and serotypes of Streptococcus pneumoniae isolated from the patients with respiratory tract infections in Hokusetsu Area of Osaka].
Topics: Anti-Bacterial Agents; Cefdinir; Cefpodoxime; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Clindamycin; Erythromycin; Humans; Minocycline; Penicillin G; Penicillins; Respiratory Tract Infections; Serotyping; Streptococcus pneumoniae | 2000 |
Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in Spain, 2004-20: a national surveillance study.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; COVID-19 Drug Treatment; Drug Resistance, Bacterial; Erythromycin; Humans; Pandemics; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; SARS-CoV-2; Serogroup; Spain; Streptococcus pneumoniae; Vaccines, Conjugate | 2022 |